Epogen
Pfizer scores approval for first Epogen/Procrit biosimilar in the US
May 16, 2018Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA
Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …
Pfizer’s biosimilar gets a second knock-back from FDA
June 23, 2017Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
Amgen unveils plan to close Epogen plant
August 14, 2012Manufacturing and Production Amgen, Epogen, cuts, omontys
Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …
Approval for Affymax and Takeda’s anaemia treatment
March 29, 2012Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys
The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …
Glass flakes lead Amgen to order Epogen and Procrit recall
September 27, 2010Manufacturing and Production Amgen, Centocor Ortho Biotech, Epogen, Procrit, manufacturing compliance, recalls
Amgen has taken what it describes as a precautionary measure and recalled lots of two of its erythropoietin-based products Epogen …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
